Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tiocarlide is a synthetic small molecule belonging to the class of N-phenylthioureas. It has been used as an antitubercular agent for the treatment of tuberculosis. Its mechanism of action involves inhibition of mycolic acid synthesis in Mycobacterium tuberculosis by targeting enzymes involved in fatty acid elongation and cell wall biosynthesis. Tiocarlide was historically used as a second-line drug for multidrug-resistant tuberculosis but has largely fallen out of use due to lower efficacy compared to modern agents and concerns about toxicity[10][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tiocarlide.